Xoma reported $-2065000 in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4717M 357M
Agenus AGEN:US $ -35.46M 18.57M
Agios Pharmaceuticals AGIO:US $ -98.44M 3.74M
Ardelyx ARDX:US $ -27.81M 7.47M
Biomarin Pharmaceutical BMRN:US $ 137.33M 203.21M
Bluebird Bio BLUE:US $ -120.35M 15.32M
Celldex Therapeutics CLDX:US $ -23.26M 2.92M
Chimerix CMRX:US -24771000 14.76M
Curis CRIS:US $ -15.13M 2.57M
Eli Lilly And LLY:US $ 2404.3M 487.1M
Emergent Biosolutions EBS:US $ 6.4M 271M
Epizyme EPZM:US $ -50926000 360K
Intercept Pharmaceuticals ICPT:US $ -10.27M 10.59M
Life Technologies LIFE:US $ -12.38M 3.74M
Macrogenics MGNX:US $ -66638000 8.4M
Novartis NOVN:VX 2.85B 290M
Novartis NVS:US $ 2852M 290M
Pfizer PFE:US $ 9873M 5297M
Prothena PRTA:US -37944000 4.85M
Regeneron Pharmaceuticals REGN:US $ 1258.5M 1381.2M
Teva Pharmaceutical Industries TEVA:US $ -713M 791M
Xoma XOMA:US $ -2065000 32.43M
YTE INCY:US $ 116.54M 5.81M